Letter

Life after prostate cancer

Time to evaluate focal therapy

BMJ 2010; 340 doi: 10.1136/bmj.c1057 (Published 23 February 2010)
Cite this as: BMJ 2010;340:c1057

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Paul Cathcart, academic clinical lecturer in urology1,
  2. Hashim Uddin Ahmed, MRC research fellow and specialist registrar in urology1,
  3. Caroline Moore, academic clinical lecturer in urology1,
  4. Mark Emberton, reader in interventional oncology1
  1. 1Division of Surgery and Interventional Sciences, University College London and University College Hospital London, London NW1 2BU
  1. pjcathcart{at}hotmail.com

    Smith and colleagues’ findings on quality of life after diagnosis and treatment of localised prostate cancer1 are neither new nor unexpected.2 3

    While much resource has gone into refining both radiotherapeutic and surgical approaches to care, the key question is: has increased specification decreased the toxicity of prostate cancer …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular